Hepcidin and the soluble transferrin receptor: significance in the pathogenesis and diagnosis of anemia of chronic diseases in patients with HIV infections

Anemia of chronic disease (ACD) in patients with human immunodeficiency virus (HIV) is a common complication that reduces quality of life and worsens prognosis. The study of hepcidin and soluble transferrin receptor (sTfR) in the pathogenesis and diagnosis of ACD remains relevant. The aim of the study was to compare the secretion of hepcidin and sTfR in patients with HIV infection who developed ACD, iron deficiency anemia (IDA), and their combination. We assessed their impact on erythrocytes and hemoglobin and determined their diagnostic significance in the differential diagnosis of ACD and IDA. Material and methods. A total of 125 HIV-infected patients were examined, who were divided into ACD, ACD/IDA, IDA, and a control group without anemia based on the criteria of Van Santen and Worwood. Patients in all groups were comparable in age and sex. Results. Comparative analysis showed that in the IDA group, the concentration of hepcidin was minimal and sTfR was maximal. In the ACD group, the concentration of sTfR did not differ from the control group, while the concentration of hepcidin was lower than that in the control group. In the ACD group, a moderate correlation was found between hepcidin, sTfR, erythrocytes, and hemoglobin. Their diagnostic significance for the differential diagnosis of ACD and IDA was found to be low. Conclusion. The study established a minor role for hepcidin and sTfR in the development of ACD in HIV patients and their low diagnostic significance for the differential diagnosis of ACD and IDA, which is significantly lower than that of ferritin. Further research into the pathogenesis of ACD in HIV-infected patients is needed.

1. WHO. Report on the Global AIDS Epidemic. In: UNAIDS, editor. Switzerland; 2019.

2. Belperio P.S. Prevalence and outcomes of anemia in individuals with human immunodeficiency virus: a systematic review of the literature. P.S. Belperio, D.C. Rhew. Am. J. Med. 2004;216 (7A);27–43.

3. Assefa M. Prevalence and correlates of anemia among HIV infected patients on highly active anti-retroviral therapy at Zewditu Memorial Hospital, Ethiopia. M. Assefa, W.E. Abegaz, A. Shewamare, G. Medhin, M. Belay. BMC Hematol. 2015;15:6.

4. Sakhin V.T., Kryukov E.V., Kazakov S.P., Gordienko A.V., Sotnikov A.V., Rukavitsyn O.A. Comparative analysis of the secretion of interleukin-6, interleukin1b, interleukin-10, tumor necrosis factor-alpha, interferon-gamma in various types of anemia in patients with HIV infection. Pulse Medical and Pharmaceutical Journal. 2023;25(2):112–123. (In Russian).

5. Frosch A.E. Iron deficiency is prevalent among HIV-infected Kenyan adults and is better measured by soluble transferrin receptor than ferritin. A.E. Frosch, G. Ayodo, E.O. Odhiambo, K. Ireland, J. Vulule, S.E. Cusick. Am. J. Trop. Med. Hyg. 2018;99(2):439–44.

6. Ganz T. Anemia of inflammation. The New England Journal of Medicine. 2019;381(12):1148–1157. PMID: 31532961. DOI: 10.1056/NEJMra1804281

7. Speeckaert M.M., Speeckaert R., Delanghe J.R. Biological and clinical aspects of soluble transferring receptor. Crit. Rev. Clin. Lab. Sci. 2010;47:213–28. DOI: 10.3109/10408363.2010.550461

8. World Health Organisation. Nutritional Anemia: Report of WHO Scientific Group. Geneva, Switzerland: World health Organisation. 1968.

9. Van Santen S., Van Dongen-Lases E.C., de Vegt F. Hepcidin and hemoglobin content parameters in the diagnosis of iron deficiency in rheumatoid arthritis patients with anemia. Arthritis Rheum. 2011;63(12):3672 –80. PMID: 22127690 DOI: 10.1002/art.30623

10. Worwood M. Iron deficiency anemia and iron overload. In: Bain B.J., Lewis S.M., Bates I., Laff an M.A. (eds). Dacie and Lewis Practical Haematology. 11th ed. Philadelphia: Churchill Livingstone. 2011:175–200. DOI: 10.1016/B978-0-7020-6696-2.00009-6

11. Clinical guidelines - HIV infection in adults. 2020 (02/16/2021) Approved by the Ministry of Health of the Russian Federation. (In Russian).

12. Trukhacheva N.V. Mathematical statistics in biomedical research using the Statistica package. Moscow: GEOTAR-Media. 2013:384. (In Russian).

13. Lopez-Calderon C., Palacios R., Cobo A., Nuno E., Ruiz J., Marquez M., Santos J. Serum ferritin in HIV-positive patients is related to immune deficiency and inflammatory activity. Int. J. STD AIDS. 2015;26(6):393–397.

14. Huibers M.H., Calis JC, Allain T.J. et al. A possible role for hepcidin in the detection of iron deficiency in severely anaemic HIV-infected patients in Malawi. PLoS ONE. 2020;15(2):e0218694. DOI: 10.1371/journal.pone.0218694

15. Lee E.J., Oh E., Park Y., Lee H., and Kim B. Soluble transferrin receptor (sTfR), ferritin, and sTfR/log ferritin index in anemic patients with nonhematologic malignancy and chronic inflammation. Clinical Chemistry. 2002;48(7):1118–1121.

16. Scholz G.A., Leichtle A.B., Scherer A. et al. The links of hepcidin and erythropoietin in the interplay of inflammation and iron deficiency in a large observational study of rheumatoid arthritis. Br. J. Haematol. 2019;186(1):101–112. DOI: 10.1111/bjh.15895